Get our Editor-in-Chief Michelle Itano's BioTechniques Q1 2026 highlights, featuring an optimized Southern blot protocol and ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries that use these ...

Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, enabling timely medical guidance and informed decision-making.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Methods developed and validated to establish the "World Bank of NK Cells" from healthy donors and cancer patients -- Single apheresis yields up to 5 billion (5×109) highly pure activated memory ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers.

Background Chromosome 19 is the most gene-dense chromosome in the human genome, with a high frequency of segmental ...

To address the demand for rapid, highly specific therapeutic candidates, Creative Biolabs has optimized its comprehensive ...